Arcus Biosciences (RCUS) Net Income (2017 - 2025)
Historic Net Income for Arcus Biosciences (RCUS) over the last 9 years, with Q3 2025 value amounting to -$135.0 million.
- Arcus Biosciences' Net Income fell 4673.91% to -$135.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$341.0 million, marking a year-over-year decrease of 2629.63%. This contributed to the annual value of -$283.0 million for FY2024, which is 781.76% up from last year.
- As of Q3 2025, Arcus Biosciences' Net Income stood at -$135.0 million, which was down 4673.91% from -$112.0 million recorded in Q1 2025.
- In the past 5 years, Arcus Biosciences' Net Income ranged from a high of $279.5 million in Q4 2021 and a low of -$135.0 million during Q3 2025
- Over the past 5 years, Arcus Biosciences' median Net Income value was -$75.5 million (recorded in 2021), while the average stood at -$58.4 million.
- Data for Arcus Biosciences' Net Income shows a peak YoY increase of 63762.48% (in 2021) and a maximum YoY decrease of 437963.78% (in 2021) over the last 5 years.
- Arcus Biosciences' Net Income (Quarter) stood at $279.5 million in 2021, then tumbled by 123.97% to -$67.0 million in 2022, then decreased by 20.9% to -$81.0 million in 2023, then dropped by 16.05% to -$94.0 million in 2024, then crashed by 43.62% to -$135.0 million in 2025.
- Its Net Income stands at -$135.0 million for Q3 2025, versus -$112.0 million for Q1 2025 and -$94.0 million for Q4 2024.